{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T05:22:51Z","timestamp":1790400171006,"version":"4.1.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2010,10,7]],"date-time":"2010-10-07T00:00:00Z","timestamp":1286409600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2011,4]]},"DOI":"10.1007\/s10549-010-1195-2","type":"journal-article","created":{"date-parts":[[2010,10,6]],"date-time":"2010-10-06T08:32:20Z","timestamp":1286353940000},"page":"771-778","source":"Crossref","is-referenced-by-count":107,"title":["Mutations in BRCA2 and PALB2 in male breast cancer cases from the United States"],"prefix":"10.1007","volume":"126","author":[{"given":"Yuan Chun","family":"Ding","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Steele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chih-Jen","family":"Kuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Greilac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan L.","family":"Neuhausen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,10,7]]},"reference":[{"issue":"4 Suppl 1","key":"1195_CR1","first-page":"S25","volume":"102","author":"JR Hecht","year":"1994","unstructured":"Hecht JR, Winchester DJ (1994) Male breast cancer. Am J Clin Pathol 102(4 Suppl 1):S25\u2013S30","journal-title":"Am J Clin Pathol"},{"key":"1195_CR2","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1093\/hmg\/5.Supplement_1.1515","volume":"5 Spec No","author":"MR Stratton","year":"1996","unstructured":"Stratton MR (1996) Recent advances in understanding of genetic susceptibility to breast cancer. Hum Mol Genet 5 Spec No:1515\u20131519","journal-title":"Hum Mol Genet"},{"key":"1195_CR3","unstructured":"American Cancer Society. Breast Cancer Facts and Figures\u00a02009\u20132010. Atlanta: American Cancer Society, Inc"},{"issue":"9510","key":"1195_CR4","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S0140-6736(06)68226-3","volume":"367","author":"IS Fentiman","year":"2006","unstructured":"Fentiman IS, Fourquet A, Hortobagyi GN (2006) Male breast cancer. Lancet 367(9510):595\u2013604","journal-title":"Lancet"},{"issue":"43","key":"1195_CR5","doi-asserted-by":"crossref","first-page":"5898","DOI":"10.1038\/sj.onc.1209879","volume":"25","author":"AC Antoniou","year":"2006","unstructured":"Antoniou AC, Easton DF (2006) Models of genetic susceptibility to breast cancer. Oncogene 25(43):5898\u20135905","journal-title":"Oncogene"},{"key":"1195_CR6","doi-asserted-by":"crossref","unstructured":"Evans DG, Susnerwala I, Dawson J, Woodward E, Maher ER, Lalloo F (2010) Risk of breast cancer in male BRCA2 carriers. J Med Genet. doi: 10.1136\/jmg.2009.075176","DOI":"10.1136\/jmg.2009.075176"},{"issue":"1","key":"1195_CR7","doi-asserted-by":"crossref","first-page":"R2","DOI":"10.1186\/bcr419","volume":"4","author":"VM Basham","year":"2002","unstructured":"Basham VM, Lipscombe JM, Ward JM, Gayther SA, Ponder BA, Easton DF, Pharoah PD (2002) BRCA1 and BRCA2 mutations in a population-based study of male breast cancer. Breast Cancer Res 4(1):R2","journal-title":"Breast Cancer Res"},{"issue":"2","key":"1195_CR8","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1089\/gte.2007.0071","volume":"12","author":"N Besic","year":"2008","unstructured":"Besic N, Cernivc B, de Greve J, Lokar K, Krajc M, Novakovic S, Zgajnar J, Teugels E (2008) BRCA2 gene mutations in Slovenian male breast cancer patients. Genet Test 12(2):203\u2013209","journal-title":"Genet Test"},{"issue":"1","key":"1195_CR9","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/ng0596-123","volume":"13","author":"FJ Couch","year":"1996","unstructured":"Couch FJ, Farid LM, DeShano ML, Tavtigian SV, Calzone K, Campeau L, Peng Y, Bogden B, Chen Q, Neuhausen S et al (1996) BRCA2 germline mutations in male breast cancer cases and breast cancer families. Nat Genet 13(1):123\u2013125","journal-title":"Nat Genet"},{"issue":"5","key":"1195_CR10","first-page":"995","volume":"59","author":"B Csokay","year":"1999","unstructured":"Csokay B, Udvarhelyi N, Sulyok Z, Besznyak I, Ramus S, Ponder B, Olah E (1999) High frequency of germ-line BRCA2 mutations among Hungarian male breast cancer patients without family history. Cancer Res 59(5):995\u2013998","journal-title":"Cancer Res"},{"issue":"1","key":"1195_CR11","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1023\/A:1008339009528","volume":"11","author":"O Diez","year":"2000","unstructured":"Diez O, Cortes J, Domenech M, Pericay C, Brunet J, Alonso C, Baiget M (2000) BRCA2 germ-line mutations in Spanish male breast cancer patients. Ann Oncol 11(1):81\u201384","journal-title":"Ann Oncol"},{"issue":"3\u20134","key":"1195_CR12","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1023\/A:1021165031643","volume":"1","author":"DG Evans","year":"2001","unstructured":"Evans DG, Bulman M, Young K, Gokhale D, Lalloo F (2001) High detection rate for BRCA2 mutations in male breast cancer families from North West England. Fam Cancer 1(3\u20134):131\u2013133","journal-title":"Fam Cancer"},{"issue":"2","key":"1195_CR13","first-page":"313","volume":"60","author":"LS Friedman","year":"1997","unstructured":"Friedman LS, Gayther SA, Kurosaki T, Gordon D, Noble B, Casey G, Ponder BA, Anton-Culver H (1997) Mutation analysis of BRCA1 and BRCA2 in a male breast cancer population. Am J Hum Genet 60(2):313\u2013319","journal-title":"Am J Hum Genet"},{"issue":"7","key":"1195_CR14","first-page":"1367","volume":"58","author":"K Haraldsson","year":"1998","unstructured":"Haraldsson K, Loman N, Zhang QX, Johannsson O, Olsson H, Borg A (1998) BRCA2 germ-line mutations are frequent in male breast cancer patients without a family history of the disease. Cancer Res 58(7):1367\u20131371","journal-title":"Cancer Res"},{"issue":"12","key":"1195_CR15","first-page":"4452","volume":"9","author":"E Kwiatkowska","year":"2003","unstructured":"Kwiatkowska E, Teresiak M, Filas V, Karczewska A, Breborowicz D, Mackiewicz A (2003) BRCA2 mutations and androgen receptor expression as independent predictors of outcome of male breast cancer patients. Clin Cancer Res 9(12):4452\u20134459","journal-title":"Clin Cancer Res"},{"issue":"11","key":"1195_CR16","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1038\/bjc.1997.574","volume":"76","author":"E Mavraki","year":"1997","unstructured":"Mavraki E, Gray IC, Bishop DT, Spurr NK (1997) Germline BRCA2 mutations in men with breast cancer. Br J Cancer 76(11):1428\u20131431","journal-title":"Br J Cancer"},{"issue":"2","key":"1195_CR17","first-page":"342","volume":"63","author":"L Ottini","year":"2003","unstructured":"Ottini L, Masala G, D\u2019Amico C, Mancini B, Saieva C, Aceto G, Gestri D, Vezzosi V, Falchetti M, De Marco M et al (2003) BRCA1 and BRCA2 mutation status and tumor characteristics in male breast cancer: a population-based study in Italy. Cancer Res 63(2):342\u2013347","journal-title":"Cancer Res"},{"issue":"3","key":"1195_CR18","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/s10549-008-0194-z","volume":"116","author":"L Ottini","year":"2009","unstructured":"Ottini L, Rizzolo P, Zanna I, Falchetti M, Masala G, Ceccarelli K, Vezzosi V, Gulino A, Giannini G, Bianchi S et al (2009) BRCA1\/BRCA2 mutation status and clinical-pathologic features of 108 male breast cancer cases from Tuscany: a population-based study in central Italy. Breast Cancer Res Treat 116(3):577\u2013586","journal-title":"Breast Cancer Res Treat"},{"issue":"6","key":"1195_CR19","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1086\/302678","volume":"65","author":"JP Struewing","year":"1999","unstructured":"Struewing JP, Coriaty ZM, Ron E, Livoff A, Konichezky M, Cohen P, Resnick MB, Lifzchiz-Mercerl B, Lew S, Iscovich J (1999) Founder BRCA1\/2 mutations among male patients with breast cancer in Israel. Am J Hum Genet 65(6):1800\u20131802","journal-title":"Am J Hum Genet"},{"issue":"5","key":"1195_CR20","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1593\/neo.04193","volume":"6","author":"K Syrjakoski","year":"2004","unstructured":"Syrjakoski K, Kuukasjarvi T, Waltering K, Haraldsson K, Auvinen A, Borg A, Kainu T, Kallioniemi OP, Koivisto PA (2004) BRCA2 mutations in 154 Finnish male breast cancer patients. Neoplasia 6(5):541\u2013545","journal-title":"Neoplasia"},{"issue":"5","key":"1195_CR21","first-page":"1079","volume":"60","author":"S Thorlacius","year":"1997","unstructured":"Thorlacius S, Sigurdsson S, Bjarnadottir H, Olafsdottir G, Jonasson JG, Tryggvadottir L, Tulinius H, Eyfjord JE (1997) Study of a single BRCA2 mutation with high carrier frequency in a small population. Am J Hum Genet 60(5):1079\u20131084","journal-title":"Am J Hum Genet"},{"issue":"1","key":"1195_CR22","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3816\/CBC.2000.n.005","volume":"1","author":"N Wolpert","year":"2000","unstructured":"Wolpert N, Warner E, Seminsky MF, Futreal A, Narod SA (2000) Prevalence of BRCA1 and BRCA2 mutations in male breast cancer patients in Canada. Clin Breast Cancer 1(1):57\u201363 discussion 64\u201355","journal-title":"Clin Breast Cancer"},{"issue":"2","key":"1195_CR23","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/ng1942","volume":"39","author":"B Xia","year":"2007","unstructured":"Xia B, Dorsman JC, Ameziane N, de Vries Y, Rooimans MA, Sheng Q, Pals G, Errami A, Gluckman E, Llera J et al (2007) Fanconi anemia is associated with a defect in the BRCA2 partner PALB2. Nat Genet 39(2):159\u2013161","journal-title":"Nat Genet"},{"issue":"6","key":"1195_CR24","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.molcel.2006.05.022","volume":"22","author":"B Xia","year":"2006","unstructured":"Xia B, Sheng Q, Nakanishi K, Ohashi A, Wu J, Christ N, Liu X, Jasin M, Couch FJ, Livingston DM (2006) Control of BRCA2 cellular and clinical functions by a nuclear partner, PALB2. Mol Cell 22(6):719\u2013729","journal-title":"Mol Cell"},{"issue":"2","key":"1195_CR25","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/ng1959","volume":"39","author":"N Rahman","year":"2007","unstructured":"Rahman N, Seal S, Thompson D, Kelly P, Renwick A, Elliott A, Reid S, Spanova K, Barfoot R, Chagtai T et al (2007) PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene. Nat Genet 39(2):165\u2013167","journal-title":"Nat Genet"},{"issue":"7133","key":"1195_CR26","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1038\/nature05609","volume":"446","author":"H Erkko","year":"2007","unstructured":"Erkko H, Xia B, Nikkila J, Schleutker J, Syrjakoski K, Mannermaa A, Kallioniemi A, Pylkas K, Karppinen SM, Rapakko K et al (2007) A recurrent mutation in PALB2 in Finnish cancer families. Nature 446(7133):316\u2013319","journal-title":"Nature"},{"issue":"6","key":"1195_CR27","doi-asserted-by":"crossref","first-page":"R83","DOI":"10.1186\/bcr1828","volume":"9","author":"WD Foulkes","year":"2007","unstructured":"Foulkes WD, Ghadirian P, Akbari MR, Hamel N, Giroux S, Sabbaghian N, Darnel A, Royer R, Poll A, Fafard E et al (2007) Identification of a novel truncating PALB2 mutation and analysis of its contribution to early-onset breast cancer in French-Canadian women. Breast Cancer Res 9(6):R83","journal-title":"Breast Cancer Res"},{"issue":"3","key":"1195_CR28","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/s10549-008-9945-0","volume":"113","author":"MJ Garcia","year":"2009","unstructured":"Garcia MJ, Fernandez V, Osorio A, Barroso A, Llort G, Lazaro C, Blanco I, Caldes T, de la Hoya M, Ramon YCT et al (2009) Analysis of FANCB and FANCN\/PALB2 fanconi anemia genes in BRCA1\/2-negative Spanish breast cancer families. Breast Cancer Res Treat 113(3):545\u2013551","journal-title":"Breast Cancer Res Treat"},{"issue":"16","key":"1195_CR29","doi-asserted-by":"crossref","first-page":"6788","DOI":"10.1073\/pnas.0701724104","volume":"104","author":"M Tischkowitz","year":"2007","unstructured":"Tischkowitz M, Xia B, Sabbaghian N, Reis-Filho JS, Hamel N, Li G, van Beers EH, Li L, Khalil T, Quenneville LA et al (2007) Analysis of PALB2\/FANCN-associated breast cancer families. Proc Natl Acad Sci USA 104(16):6788\u20136793","journal-title":"Proc Natl Acad Sci USA"},{"key":"1195_CR30","doi-asserted-by":"crossref","first-page":"209","DOI":"10.2307\/2276774","volume":"22","author":"E Wilson","year":"1927","unstructured":"Wilson E (1927) Probable inference, the law of succession, and statistical inference. J Am Stat Assoc 22:209\u2013212","journal-title":"J Am Stat Assoc"},{"issue":"5","key":"1195_CR31","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1086\/521032","volume":"81","author":"DF Easton","year":"2007","unstructured":"Easton DF, Deffenbaugh AM, Pruss D, Frye C, Wenstrup RJ, Allen-Brady K, Tavtigian SV, Monteiro AN, Iversen ES, Couch FJ et al (2007) A systematic genetic assessment of 1, 433 sequence variants of unknown clinical significance in the BRCA1 and BRCA2 breast cancer-predisposition genes. Am J Hum Genet 81(5):873\u2013883","journal-title":"Am J Hum Genet"},{"issue":"2","key":"1195_CR32","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/ng1947","volume":"39","author":"S Reid","year":"2007","unstructured":"Reid S, Schindler D, Hanenberg H, Barker K, Hanks S, Kalb R, Neveling K, Kelly P, Seal S, Freund M et al (2007) Biallelic mutations in PALB2 cause Fanconi anemia subtype FA-N and predispose to childhood cancer. Nat Genet 39(2):162\u2013164","journal-title":"Nat Genet"},{"issue":"9","key":"1195_CR33","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1038\/embor.2009.126","volume":"10","author":"AW Oliver","year":"2009","unstructured":"Oliver AW, Swift S, Lord CJ, Ashworth A, Pearl LH (2009) Structural basis for recruitment of BRCA2 by PALB2. EMBO Rep 10(9):990\u2013996","journal-title":"EMBO Rep"},{"issue":"17","key":"1195_CR34","doi-asserted-by":"crossref","first-page":"3894","DOI":"10.1093\/nar\/gkf493","volume":"30","author":"V Ramensky","year":"2002","unstructured":"Ramensky V, Bork P, Sunyaev S (2002) Human non-synonymous SNPs: server and survey. Nucleic Acids Res 30(17):3894\u20133900","journal-title":"Nucleic Acids Res"},{"issue":"14","key":"1195_CR35","doi-asserted-by":"crossref","first-page":"3176","DOI":"10.1093\/bioinformatics\/bti486","volume":"21","author":"C Ferrer-Costa","year":"2005","unstructured":"Ferrer-Costa C, Gelpi JL, Zamakola L, Parraga I, de la Cruz X, Orozco M (2005) PMUT: a web-based tool for the annotation of pathological mutations on proteins. Bioinformatics 21(14):3176\u20133178","journal-title":"Bioinformatics"},{"issue":"1","key":"1195_CR36","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1002\/humu.10097","volume":"20","author":"IL Andrulis","year":"2002","unstructured":"Andrulis IL, Anton-Culver H, Beck J, Bove B, Boyd J, Buys S, Godwin AK, Hopper JL, Li F, Neuhausen SL et al (2002) Comparison of DNA- and RNA-based methods for detection of truncating BRCA1 mutations. Hum Mutat 20(1):65\u201373","journal-title":"Hum Mutat"},{"issue":"1","key":"1195_CR37","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1002\/(SICI)1098-1004(1997)10:1<65::AID-HUMU9>3.0.CO;2-L","volume":"10","author":"A Jordanova","year":"1997","unstructured":"Jordanova A, Kalaydjieva L, Savov A, Claustres M, Schwarz M, Estivill X, Angelicheva D, Haworth A, Casals T, Kremensky I (1997) SSCP analysis: a blind sensitivity trial. Hum Mutat 10(1):65\u201370","journal-title":"Hum Mutat"},{"issue":"10","key":"1195_CR38","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1054\/bjoc.2000.1407","volume":"83","author":"Anglian Breast Cancer Study Group","year":"2000","unstructured":"Anglian Breast Cancer Study Group (2000) Prevalence and penetrance of BRCA1 and BRCA2 mutations in a population-based series of breast cancer cases. Br J Cancer 83(10):1301\u20131308","journal-title":"Br J Cancer"},{"issue":"1","key":"1195_CR39","doi-asserted-by":"crossref","first-page":"e5","DOI":"10.1136\/jmg.2004.025056","volume":"42","author":"SW Kim","year":"2005","unstructured":"Kim SW, Lee CS, Fey JV, Borgen PI, Boyd J (2005) Prevalence of BRCA2 mutations in a hospital based series of unselected breast cancer cases. J Med Genet 42(1):e5","journal-title":"J Med Genet"},{"issue":"27","key":"1195_CR40","doi-asserted-by":"crossref","first-page":"18302","DOI":"10.1074\/jbc.M109.016717","volume":"284","author":"SM Sy","year":"2009","unstructured":"Sy SM, Huen MS, Zhu Y, Chen J (2009) PALB2 regulates recombinational repair through chromatin association and oligomerization. J Biol Chem 284(27):18302\u201318310","journal-title":"J Biol Chem"},{"issue":"5","key":"1195_CR41","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1101\/gr.176601","volume":"11","author":"PC Ng","year":"2001","unstructured":"Ng PC, Henikoff S (2001) Predicting deleterious amino acid substitutions. Genome Res 11(5):863\u2013874","journal-title":"Genome Res"},{"issue":"1","key":"1195_CR42","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s10549-009-0673-x","volume":"121","author":"A Sauty de Chalon","year":"2010","unstructured":"Sauty de Chalon A, Teo Z, Park DJ, Odefrey FA, Hopper JL, Southey MC (2010) Are PALB2 mutations associated with increased risk of male breast cancer? Breast Cancer Res Treat 121(1):253\u2013255","journal-title":"Breast Cancer Res Treat"},{"issue":"4","key":"1195_CR43","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.coph.2008.06.016","volume":"8","author":"CJ Lord","year":"2008","unstructured":"Lord CJ, Ashworth A (2008) Targeted therapy for cancer using PARP inhibitors. Curr Opin Pharmacol 8(4):363\u2013369","journal-title":"Curr Opin Pharmacol"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-010-1195-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10549-010-1195-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-010-1195-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,5]],"date-time":"2019-06-05T07:37:58Z","timestamp":1559720278000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10549-010-1195-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10,7]]},"references-count":43,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,4]]}},"alternative-id":["1195"],"URL":"https:\/\/doi.org\/10.1007\/s10549-010-1195-2","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,10,7]]}}}